论药价“虚高”的综合治理

• 作 者: 卢水清 罗群林
• 机 构: 湖北省物价局,湖北省物价局
• 出 处: 中国物价
• 发表日期: 2002年03期
• 关键词: 招标采购 质量管理规范 销售收入 医药代表 零售价格指数 价格改革 医疗保险 流通体制 阳光采购 公费医疗体制

一、治理药价“虚高”已见成效药价太高、医药费用支出增长过快，是近几年来倍受社会各界广泛关注的一个焦点问题。为了切实减轻群众医药费负担，政府治理药价“虚高”的力度在不断加大：１９９７年以来，国家计委先后１０次降低了中央管理的药品价格，涉及近千个品种、规格，

First, the management of drug prices “virtual high” has been to see the effectiveness of drug prices are too high, the rapid growth of medical expenses, in recent years has drawn much attention from all walks of life a focus issue. In order to effectively reduce the burden on the masses of medical expenses, the government has been continuously increasing the “virtual highs” in drug prices: since 1997, the State Development Planning Commission has successively lowered the prices of centrally administered medicines by 10 times, involving nearly a thousand varieties, specifications,